Share This

Related Topics News -

     
 Title only   |   Print    Next page > 
     
《大行》高盛微降國藥目標價至21.17元 首季業績疲弱

2024-05-02T  
《港股》恆指收升16點 匯控績後揚逾2% 海爾智家漲近8%

2024-04-30T  
《大行》大摩降國藥目標價至27元 評級「增持」

2024-04-30T  
《港股》恆指升35點 油股及航運股漲 匯控靠穩

2024-04-30T  
《藍籌》國藥控股首季純利14.2億元人民幣跌10.7%

2024-04-29T  
國藥控股跌近一成 上季少賺10.7%

2024-04-29T  
國藥擬發行共300億人幣非金融企業債務融資工具

2024-04-29T  
國藥集團原總工楊曉明等被罷免全國人大代表職務

2024-04-29T  
國藥附屬國藥一致首季淨利潤3.89億人民幣 增長7.3%

2024-04-26T  
副總理劉國中赴上海調研 稱推動醫學科技創新

2024-04-25T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.